Antineoplastic AgentsNeoplasmsDrug Resistance, NeoplasmDrug Screening Assays, AntitumorCell Line, TumorDrug Resistance, MultipleDrug ResistanceRadiation, IonizingApoptosisRadiation DosageDoxorubicinDrug Delivery SystemsCell SurvivalRadiation InjuriesDrug DesignCisplatinMice, NudeDrug DiscoveryAntineoplastic Agents, PhytogenicTumor Cells, CulturedCell ProliferationXenograft Model Antitumor AssaysRadiation ToleranceDose-Response Relationship, RadiationBreast NeoplasmsMolecular Targeted TherapyAntibiotics, AntineoplasticDrug CarriersInhibitory Concentration 50Drug Resistance, MicrobialP-GlycoproteinGene Expression Regulation, NeoplasticDose-Response Relationship, DrugDrug Resistance, BacterialMolecular StructureRadiationCell CycleNeoplasm ProteinsDrugs, InvestigationalRadiation ProtectionEnzyme InhibitorsPaclitaxelDrug ApprovalTime FactorsClinical Trials as TopicColonic NeoplasmsDrug Evaluation, PreclinicalSignal TransductionRadiation MonitoringDNA DamageProstatic NeoplasmsMutationDrug SynergismCamptothecinEtoposideLung NeoplasmsBlotting, WesternEllipticinesModels, BiologicalProtein Kinase InhibitorsMolecular Sequence DataOvarian NeoplasmsFluorouracilNaphthoquinonesModels, MolecularPlant ExtractsRNA, MessengerGene Expression ProfilingAntineoplastic Combined Chemotherapy ProtocolsNeoplasm TransplantationEarly Detection of CancerCombined Modality TherapyTumor Suppressor Protein p53Disease ResistancePyrimidinesStructure-Activity RelationshipPiperazinesMedical OncologyAntimetabolites, AntineoplasticReverse Transcriptase Polymerase Chain ReactionBase SequenceRadiation-Sensitizing AgentsRadiation OncologyDrug IndustryAnti-Bacterial AgentsCell DivisionDNA Topoisomerases, Type IIUnited States Food and Drug AdministrationVascular ResistanceDrug CostsGamma RaysProdrugsDNAUnited StatesDrug Resistance, ViralRNA, Small InterferingFlow CytometryMultidrug Resistance-Associated ProteinsProto-Oncogene Proteins c-bcl-2Topoisomerase I Inhibitors